Two Sigma Securities’s Jupiter Neurosciences JUNS Stock Holding History

Two Sigma Securities’s Portfolio JUNS Stock Details JUNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-912	Closed	-$41.7K	–	2218
2025 Q1	$41.7K	Buy	+912	New	+$148K	0.01%	1018

Other funds holding JUNS

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Two Sigma Securities's JUNS Position: Q2 2025 in Review

Two Sigma Securities sold out of Jupiter Neurosciences (JUNS) in Q2 2025, closing a stake of 912 shares — an estimated $41.7K sold.

Two Sigma Securities first reported a position in JUNS in Q1 2025 and held it in 1 quarter. The position peaked at $41.7K in Q1 2025. 2 funds tracked by Wall St. Rank hold JUNS as of Q2 2025.

Two Sigma Securities reported no remaining Jupiter Neurosciences position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 912 Jupiter Neurosciences shares in Q2 2025, an estimated $41.7K.
Two Sigma Securities first reported a position in Jupiter Neurosciences in Q1 2025 and held it in 1 quarter.
Two Sigma Securities's Jupiter Neurosciences position peaked at $41.7K in Q1 2025.
2 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.